160 related articles for article (PubMed ID: 1464014)
1. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
[TBL] [Abstract][Full Text] [Related]
2. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
3. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
4. Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells.
Fang B; Song Y; Zhao RC; Han Q; Cao Y
Am J Hematol; 2007 Aug; 82(8):772-3. PubMed ID: 17573692
[No Abstract] [Full Text] [Related]
5. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
8. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
9. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
10. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
[No Abstract] [Full Text] [Related]
11. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
12. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
13. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.
Selleri C; Raiola A; De Rosa G; Luciano L; Pezzullo L; Picardi M; Rotoli B
Bone Marrow Transplant; 1998 Sep; 22(6):605-7. PubMed ID: 9758354
[TBL] [Abstract][Full Text] [Related]
14. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
Paltiel O; Cournoyer D; Rybka W
Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
[TBL] [Abstract][Full Text] [Related]
15. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
Roychowdhury DF; Linker CA
Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
[TBL] [Abstract][Full Text] [Related]
16. ABO-incompatible bone marrow transplantation.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
[TBL] [Abstract][Full Text] [Related]
17. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
20. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
